Flood of myocarditis/vaccine research

It is hard to keep up with it all. Mansanguan’s paper that demonstrated very high rates of cardiac inflammation following Pfizer vaccination in teens was published just over a month ago as a pre-print. Since that time, a number of papers on the same topic have come out.

Using Google Scholar search “covid vaccine myocarditis” and looking at studies released over the past 31 days yields:

Asakura’s fulminant myocarditis case report, Murase’s series of 5 children with post-vaccine myocarditis, Marigliano’s case, Satomi’s autopsy case, Sergi’s cautionary opinion paper (Canadian pathologist!), Formanek’s adolescent case, Voltarelli’s myocarditis/heart failure case, Nishibayashi’s vaccine myocarditis in 13 year-old twins, Morita’s teen booster case, Ciofani’s myositis case that had false positive troponin, Rodriguez’s autoimmune reactions review and case series, Aldana-Bitar’s case, Kirkpatrick’s commentary regarding MRI for post-vaccine myocarditis, Cadegiani’s theory that catecholamine surge might be responsible for vaccine myocarditis, Banala’s case, and Zaidi’s commentary on delaying covid vaccines after cardiac surgery.

Sixteen studies in a month.

This is a rate of approximately one relevant study regarding mRNA vaccines and myocarditis appearing every two days. I predict this rate of publication will increase over coming months, as the peak of mRNA vaccine myocarditis likely occurred in summer-fall 2021, and there appears to be roughly 12 month lag in publication of academic articles, on average, from the time the data is collected.

Although two hundred or so case studies or case series on mRNA vaccine myocarditis have been published to date, there are still gaps in the literature: 1) how to diagnose it; 2) how to treat it; 3) how to follow up; 4) is there a relationship to sudden death.

Among these studies, I have not included a smaller number of commentaries that dismiss the phenomenon of vaccine myocarditis as unimportant.